Lenk Robert P 4
4 · PLUS THERAPEUTICS, INC. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Lenk Robert P
Director
Transactions
- Purchase
Common Stock
2023-11-10$1.45/sh+2,000$2,900→ 19,160 total - Purchase
Common Stock
2023-11-13$1.43/sh+4,000$5,720→ 23,160 total
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.